季節性インフルエンザワクチンの世界市場（2023年版）：ワクチンタイプ別（不活化、弱毒化）、価数別（4価、3価）、年齢層別、流通チャネル別、地域別、国別の分析：市場インサイトと予測（2019-2029年）

Global Seasonal Influenza Vaccine Market (2023 Edition): Analysis By Vaccine Type (Inactivated, Live Attenuated), Valency (Quadrivalent, Trivalent), Age Group, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

エグゼクティブ・サマリーこの調査レポートは世界の季節性インフルエンザワクチン市場を分析・予測したAzoth Analyticsの市場調査報告書です、2019-2022年の過去期間、2023年の予測期間、2024-2029年の予測期... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Azoth Analytics アーゾスアナリティクス	2023年7月1日	US$2,450 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	280	英語

サマリー

エグゼクティブ・サマリー

この調査レポートは世界の季節性インフルエンザワクチン市場を分析・予測したAzoth Analyticsの市場調査報告書です、2019-2022年の過去期間、2023年の予測期間、2024-2029年の予測期間について、ワクチンタイプ別（不活化インフルエンザワクチン-IIV、生ワクチン-LAIV）、価数別（4価、3価）、年齢層別（小児科、成人、高齢者）、流通チャネル別（病院、薬局、政府供給）を分析しています。

この調査レポートは、地域（米州、欧州、APAC、中東アフリカ）と10カ国（米国、カナダ、英国、ドイツ、フランス、スペイン、中国、日本、オーストラリア、韓国）の詳細な分析をカバーしています。さらに、市場規模、年間成長率、将来性分析、市場プレイヤーの競合調査、投資機会、需要予測などのデータも掲載しています。

また調査レポートは、成長指標、阻害要因、需給リスク、その他の重要な統計、市場の進化に関連する現在および将来の市場動向の完全な評価も行っています。

季節性インフルエンザワクチンの世界市場は、2022年の58億米ドルから2029年末までに93億米ドルを創出すると予測される。季節性インフルエンザワクチンの世界市場にとって好ましい成長要素は、気象条件の変化、呼吸器疾患の急速な感染、意識の高まり、小売需要の増加である。インフルエンザは世界的に重大な健康問題であり、毎年かなりの疾病、入院、死亡の負担を引き起こしている。WHOによると、世界中で毎年推定100万人が季節性インフルエンザに感染し、そのうち毎年推定29〜65万人がインフルエンザが原因で死亡している。

2024〜2029年の予測期間中、世界の季節性インフルエンザワクチンのCAGRは7.61%で拡大すると予想される。世界の季節性インフルエンザワクチンは、インフルエンザ予防に対する意識の高まり、医療費の増加、予防接種プログラムに対する政府のイニシアチブの高まりによって牽引されている。

季節性インフルエンザの予防と制圧は、主に毎年のワクチン接種によって達成される。インフルエンザ・ワクチンは、最も流行しているウイルス株を予防するために毎年処方されます。市販されているインフルエンザ・ワクチンにはさまざまな種類があります。最も一般的なものには、3価ワクチン（3種類のインフルエンザ株から予防）や4価ワクチン（4種類のインフルエンザ株から予防）があります。これらのワクチンは、注射（不活化ワクチン）または点鼻（弱毒生ワクチン）により投与されます。

小売薬局では、一般の人々が季節性インフルエンザ・ワクチンを簡単に入手することができます。薬局は地域社会に数多く存在するため、人々は予約や医療機関への訪問を必要とせず、便利に予防接種を受けることができます。

季節性インフルエンザ・ワクチン市場でデジタル技術と追跡システムを活用することは、ワクチン配布の改善、ワクチン接種キャンペーンの強化、ワクチンの安全性の確保、データ主導の意思決定を可能にする機会を提供する。デジタル・ソリューションの力を活用することで、関係者はワクチン配布を最適化し、ワクチン摂取率を向上させ、最終的にはインフルエンザの予防・制御活動の向上に貢献することができる。

レポートの範囲

- このレポートは季節性インフルエンザワクチン市場を金額（百万米ドル）別に分析しています。

- 季節性インフルエンザワクチン市場の過去期間2019-2022年、推定期間2023年、予測期間2024-2029年の分析を紹介します。

- 季節性インフルエンザワクチン市場をワクチンタイプ別（不活化インフルエンザワクチン（IIV）、弱毒化インフルエンザワクチン（LAIV））に分析しています。

- 季節性インフルエンザワクチン市場を価数（4価、3価）別に分析しています。

- 季節性インフルエンザワクチン市場を年齢層別（小児科、成人、高齢者）に分析しています。

- 季節性インフルエンザワクチン市場を流通チャネル別（病院、薬局、政府供給）に分析しています。

- 本レポートの主要な洞察は、SWOTおよびポーターのファイブフォース分析の枠組みを通して提示されています。また、市場の魅力を地域別、サービス別、運用形態別、エンドユーザー別に紹介しています。

- また、業界の主な機会、動向、促進要因、課題についても分析しています。

- 競合の動向、戦略、M&A、新製品開発についても追跡しています。本レポートで分析対象とした企業は、CSL Seqirus、グラクソ・スミスクライン、サノフィ、アストラゼネカ、アボット・ラボラトリーズ、ヴィアトリス、Sinovac Biotech、Serum Institute of India、第一三共、Dalian Aleph Biomedicalなどです。

ページTOPに戻る

1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology

2. Strategic Recommendations

2.1 Leveraging digital technologies and tracking systems

2.2 Improved vaccine distribution and access

3. Global Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

3.1 Impact Analysis of Macro Economic Factors on Seasonal Influenza Vaccine Market

3.2 Prequalified Seasonal Influenza Vaccine Worldwide

3.3 Influenza Vaccination Rates

3.4 Quadrivalent Influenza Vaccine Composition

3.5 Average Price Analysis

3.6 Global Seasonal Influenza Vaccine Market: Dashboard

3.7 Global Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

3.8 Global Seasonal Influenza Vaccine Market: Market Production Volume and CAGR, 2019-2029 (in Billion Doses)

3.9 Degree of Impact of Covid 19 on Influenza Vaccine Market

3.10 Global Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

3.10.1 Global Seasonal Influenza Vaccine Market, By Vaccine Type Overview

3.10.2 Global Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)

3.10.3 Global Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)

3.11 Global Seasonal Influenza Vaccine Market Segmentation : By Valency

3.11.1 Global Seasonal Influenza Vaccine Market, By Valency Overview

3.11.2 Americas Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

3.11.3 Americas Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

3.12 Global Seasonal Influenza Vaccine Market Segmentation : By Age Group

3.12.1 Global Seasonal Influenza Vaccine Market, By Age Group Overview

3.12.2 Global Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

3.12.3 Global Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

3.12.4 Global Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

3.13 Global Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

3.13.1 Global Seasonal Influenza Vaccine Market, By Distribution Channel Overview

3.13.2 Global Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)

3.13.3 Global Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)

3.13.4 Global Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

4. Global Seasonal Influenza Vaccine Market, Regional Analysis

4.1 Regional Coverage of the Study

4.2 Regional Snapshot

5. Americas Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

5.1 Americas Seasonal Influenza Vaccine Market: Snapshot

5.2 Americas Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.3 Americas Seasonal Influenza Vaccine Market: Key Factors

5.4 Americas Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

5.4.1 Americas Seasonal Influenza Vaccine Market, By Vaccine Type Overview

5.4.2 Americas Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)

5.4.3 Americas Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)

5.5 Americas Seasonal Influenza Vaccine Market Segmentation : By Valency

5.5.1 Americas Seasonal Influenza Vaccine Market, By Valency Overview

5.5.2 Americas Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

5.5.3 Americas Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

5.6 Americas Seasonal Influenza Vaccine Market Segmentation : By Age Group

5.6.1 Americas Seasonal Influenza Vaccine Market, By Age Group Overview

5.6.2 Americas Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

5.6.3 Americas Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

5.6.4 Americas Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

5.7 Americas Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

5.7.1 Americas Seasonal Influenza Vaccine Market, By Distribution Channel Overview

5.7.2 Americas Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)

5.7.3 Americas Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)

5.7.4 Americas Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

5.8 Americas Seasonal Influenza Vaccine Market Segmentation : By Country

5.8.1 United States Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.8.1.1 United States Seasonal Influenza Vaccine Market, By Vaccine Type

5.8.1.2 United States Seasonal Influenza Vaccine Market, By Valency

5.8.1.3 United States Seasonal Influenza Vaccine Market, By Age Group

5.8.1.4 United States Seasonal Influenza Vaccine Market, By Distribution Channel

5.8.2 Canada Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.8.2.1 Canada Seasonal Influenza Vaccine Market, By Vaccine Type

5.8.2.2 Canada Seasonal Influenza Vaccine Market, By Valency

5.8.2.3 Canada Seasonal Influenza Vaccine Market, By Age Group

5.8.2.3 Canada Seasonal Influenza Vaccine Market, By Distribution Channel

5.8.3 Rest of Americas Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

5.8.3.1 Rest of Americas Seasonal Influenza Vaccine Market, By Vaccine Type

5.8.3.2 Rest of Americas Seasonal Influenza Vaccine Market, By Valency

5.8.3.3 Rest of Americas Seasonal Influenza Vaccine Market, By Age Group

5.8.3.3 Rest of Americas Seasonal Influenza Vaccine Market, By Distribution Channel

6. Europe Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

6.1 Europe Seasonal Influenza Vaccine Market Segmentation: Snapshot

6.2 Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.3 Europe Seasonal Influenza Vaccine Market: Key Factors

6.4 Europe Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Vaccine Overview

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , By Inactivated Influenza Vaccine (IIV) Value, 2019H-2029F (USD Million & CAGR)

6.4.2 Europe Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)

6.5 Europe Seasonal Influenza Vaccine Market Segmentation : By Valency

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Valency Overview

6.5.1 Europe Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

6.5.2 Europe Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

6.6 Europe Seasonal Influenza Vaccine Market Segmentation : By Age Group

6.6.1 Europe Seasonal Influenza Vaccine Market, By Age Group Overview

6.6.2 Europe Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

6.6.3 Europe Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

6.6.4 Europe Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

6.7 Europe Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

6.1 Europe Seasonal Influenza Vaccine Market Segmentation: Snapshot

6.2 Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.3 Europe Seasonal Influenza Vaccine Market: Key Factors

6.4 Europe Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Vaccine Overview

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , By Inactivated Influenza Vaccine (IIV) Value, 2019H-2029F (USD Million & CAGR)

6.4.2 Europe Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)

6.5 Europe Seasonal Influenza Vaccine Market Segmentation : By Valency

6.4.1 Europe Seasonal Influenza Vaccine Market Size, By , Valency Overview

6.5.1 Europe Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

6.5.2 Europe Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

6.6 Europe Seasonal Influenza Vaccine Market Segmentation : By Age Group

6.6.1 Europe Seasonal Influenza Vaccine Market, By Age Group Overview

6.6.2 Europe Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

6.6.3 Europe Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

6.6.4 Europe Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

6.7 Europe Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

6.7.1 Europe Seasonal Influenza Vaccine Market, By Distribution Channel Overview

6.7.2 Europe Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)

6.7.3 Europe Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)

6.7.4 Europe Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

6.8 Europe Seasonal Influenza Vaccine Market Segmentation : By Country

6.8.1 Germany Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.8.1.1 Germany Seasonal Influenza Vaccine Market, By Vaccine Type

6.8.1.2 Germany Seasonal Influenza Vaccine Market, By Valency

6.8.1.3 Germany Seasonal Influenza Vaccine Market, By Age Group

6.8.1.4 Germany Seasonal Influenza Vaccine Market, By Distribution Channel

6.8.2 United Kingdom Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.8.2.1 United Kingdom Seasonal Influenza Vaccine Market, By Vaccine Type

6.8.2.2 United Kingdom Seasonal Influenza Vaccine Market, By Valency

6.8.2.3 United Kingdom Seasonal Influenza Vaccine Market, By Age Group

6.8.2.4 United Kingdom Seasonal Influenza Vaccine Market, By Distribution Channel

6.9.3 France Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.9.3.1 France Seasonal Influenza Vaccine Market, By Vaccine Type

6.9.3.2 France Seasonal Influenza Vaccine Market, By Valency

6.9.3.3 France Seasonal Influenza Vaccine Market, By Age Group

6.9.3.4 France Seasonal Influenza Vaccine Market, By Distribution Channel

6.9.4 Spain Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.9.4.1 Spain Seasonal Influenza Vaccine Market, By Vaccine Type

6.9.4.2 Spain Seasonal Influenza Vaccine Market, By Valency

6.9.4.3 Spain Seasonal Influenza Vaccine Market, By Age Group

6.9.4.4 Spain Seasonal Influenza Vaccine Market, By Distribution Channel

6.9.5 Rest of Europe Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

6.9.5.1 Rest of Europe Seasonal Influenza Vaccine Market, By Vaccine Type

6.9.5.2 Rest of Europe Seasonal Influenza Vaccine Market, By Valency

6.9.5.3 Rest of Europe Seasonal Influenza Vaccine Market, By Age Group

6.9.5.4 Rest of Europe Seasonal Influenza Vaccine Market, By Distribution Channel

7. Asia Pacific Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

7.1 Asia Pacific Seasonal Influenza Vaccine Market: Snapshot

7.2 Asia Pacific Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.3 Asia Pacific Seasonal Influenza Vaccine Market: Key Factors

7.4 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

7.4.1 Asia Pacific Seasonal Influenza Vaccine Market, By Vaccine Type Overview

7.4.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)

7.4.3 Asia Pacific Seasonal Influenza Vaccine Market Size, Live Attenuated Influenza Vaccine (LIIV) Museum, By Value, 2019H-2029F (USD Million & CAGR)

7.5 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Valency

7.5.1 Asia Pacific Seasonal Influenza Vaccine Market, By Valency Overview

7.5.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

7.5.3 Asia Pacific Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

7.6 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Age Group

7.6.1 Asia Pacific Seasonal Influenza Vaccine Market, By Age Group Overview

7.6.2 Asia Pacific Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

7.6.3 Asia Pacific Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

7.6.4 Asia Pacific Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

7.7 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

7.7.1 Asia Pacific Seasonal Influenza Vaccine Market, By Distribution Channel Overview

7.7.2 Asia Pacific Seasonal Influenza Vaccine Market, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)

7.7.3 Asia Pacific Seasonal Influenza Vaccine Market, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)

7.7.4 Asia Pacific Seasonal Influenza Vaccine Market, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

7.8 Asia Pacific Seasonal Influenza Vaccine Market Segmentation : By Country

7.8.1 China Seasonal Influenza Vaccine Market Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.1.1 China Seasonal Influenza Vaccine Market, By Vaccine Type

7.8.1.2 China Seasonal Influenza Vaccine Market, By Valency

7.8.1.3 China Seasonal Influenza Vaccine Market, By Age Group

7.8.1.4 China Seasonal Influenza Vaccine Market, By Distribution Channel

7.8.2 Japan Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.2.1 Japan Seasonal Influenza Vaccine Market, By Vaccine Type

7.8.2.2 Japan Seasonal Influenza Vaccine Market, By Valency

7.8.2.3 Japan Seasonal Influenza Vaccine Market, By Age Group

7.8.1.4 Japan Seasonal Influenza Vaccine Market, By Distribution Channel

7.8.3 Australia Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.3.1 Australia Seasonal Influenza Vaccine Market, By Vaccine Type

7.8.3.2 Australia Seasonal Influenza Vaccine Market, By Valency

7.8.3.3 Australia Seasonal Influenza Vaccine Market, By Age Group

7.8.3.4 Australia Seasonal Influenza Vaccine Market, By Distribution Channel

7.8.4 South Korea Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.3.1 South Korea Seasonal Influenza Vaccine Market, By Vaccine Type

7.8.3.2 South Korea Seasonal Influenza Vaccine Market, By Valency

7.8.3.3 South Korea Seasonal Influenza Vaccine Market, By Age Group

7.8.3.4 Australia Seasonal Influenza Vaccine Market, By Distribution Channel

7.8.5 Rest of APAC Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

7.8.5.1 Rest of APAC Seasonal Influenza Vaccine Market, By Vaccine Type

7.8.5.2 Rest of APAC Seasonal Influenza Vaccine Market, By Valency

7.8.5.3 Rest of APAC Seasonal Influenza Vaccine Market, By Age Group

7.8.5.4 Rest of APAC Seasonal Influenza Vaccine Market, By Distribution Channel

8. Middle East & Africa Seasonal Influenza Vaccine Market: Historic and Forecast (2019-2029)

8.1 Middle East & Africa Seasonal Influenza Vaccine Market: Snapshot

8.2 Middle East & Africa Seasonal Influenza Vaccine Market: Market Size and CAGR, 2019-2029 (USD Million & CAGR)

8.3 Middle East & Africa Seasonal Influenza Vaccine Market: Key Factors

8.4 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Vaccine Type

8.4.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Vaccine Type Overview

8.4.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Inactivated Influenza Vaccine (IIV), By Value, 2019H-2029F (USD Million & CAGR)

8.4.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Live Attenuated Influenza Vaccine (LIIV), By Value, 2019H-2029F (USD Million & CAGR)

8.5 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Valency

8.5.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Valency Overview

8.5.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Quadrivalent, By Value, 2019H-2029F (USD Million & CAGR)

8.5.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Trivalent, By Value, 2019H-2029F (USD Million & CAGR)

8.6 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Age Group

8.6.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Age Group Overview

8.6.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Pediatrics, By Value, 2019H-2029F (USD Million & CAGR)

8.6.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Adults, By Value, 2019H-2029F (USD Million & CAGR)

8.6.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Elderly, By Value, 2019H-2029F (USD Million & CAGR)

8.7 Middle East & Africa Seasonal Influenza Vaccine Market Segmentation : By Distribution Channel

8.7.1 Middle East & Africa Seasonal Influenza Vaccine Market, By Distribution Channel Overview

8.7.2 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Hospitals, By Value, 2019H-2029F (USD Million & CAGR)

8.7.3 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Pharmacies, By Value, 2019H-2029F (USD Million & CAGR)

8.7.4 Middle East & Africa Seasonal Influenza Vaccine Market Size, By Government Supply, By Value, 2019H-2029F (USD Million & CAGR)

9. Market Dynamics

9.1 Impact assessment of Market Dynamics on Global Seasonal Influenza Vaccine Market

9.2 Drivers

9.3 Restraints

9.4 Trends

10. Industry Ecosystem Analysis

10.1 Macro-Economic Factor Assessment

10.2 Porter Analysis

11. Competitive Positioning

11.1 Recommended Seasonal Influenza Vaccines for Different Age Groups

11.2 Market Share of Prominent Companies

11.3 Company Profiling

11.3.1 CSL Seqirus

11.3.2 GlaxoSmithKline

11.3.3 Sanofi

11.3.4 AstraZeneca PLC

11.3.5 Abbott Laboratories

11.3.6 Viatris

11.3.7 Sinovac Biotech

11.3.8 Serum Institute of India

11.3.9 Daiichi Sankyo

11.3.10 Dalian Aleph Biomedical

ページTOPに戻る

Table of Contents

Summary

Executive Summary

Azoth Analytics has released a research report titled “Global Seasonal Influenza Vaccine Market (2023 Edition)” which provides a complete analysis of the Global Seasonal Influenza Vaccine industry in terms of market segmentation By Vaccine Type (Inactivated Influenza Vaccine -IIV, Live Attenuated Influenza Vaccine - LAIV), Valency (Quadrivalent, Trivalent), Age Group (Pediatrics, Adults, Elderly) and By Distribution Channel (Hospitals, Pharmacies, Government Supply) for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 10 countries (United States, Canada, United Kingdom, Germany, France, Spain, China, Japan, Australia, South Korea). Additionally, the research report presents data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and demand forecast.

The research report also assesses growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market evolution.

The Global Seasonal Influenza Vaccine Market is expected to generate USD 9.3 Billion by the end of 2029, up from USD 5.8 Billion in 2022. A favourable growth element for the Global Seasonal Influenza Vaccine market is the changing weather conditions, rapid transmissions of respiratory diseases, increasing awareness, and increasing demand for retail. Influenza is a significant global health concern, causing a considerable burden of illness, hospitalizations, and deaths each year. As per WHO, an estimated 1 Million people worldwide are infected by seasonal influenza every year, out of which an estimated 290,000 – 650,000 deaths occur due to flu each year.

During the forecast period, 2024-2029, Global Seasonal Influenza Vaccines expected to expand at a CAGR of 7.61%. The global seasonal influenza vaccine is driven by increasing awareness about flu prevention, rising healthcare expenditure, and growing government initiatives for immunization programs.

Prevention and control of seasonal influenza are primarily achieved through annual vaccination. The flu vaccine is formulated each year to protect against the most prevalent strains of the virus. There are different types of influenza vaccines available in the market. The most common ones include trivalent vaccines (protect against three flu strains) and quadrivalent vaccines (protect against four flu strains). These vaccines may be administered through injection (inactivated vaccine) or nasal spray (live attenuated vaccine).

Retail pharmacies provide easy access to seasonal influenza vaccines for the general population. With numerous pharmacy locations in communities, people can conveniently receive their vaccinations without the need for appointments or visits to healthcare facilities, which may be more time-consuming and less accessible.

Leveraging digital technologies and tracking systems in the seasonal influenza vaccine market offers opportunities to improve vaccine distribution, enhance vaccination campaigns, ensure vaccine safety, and enable data-driven decision-making. By harnessing the power of digital solutions, stakeholders can optimize vaccine delivery, increase vaccine uptake, and ultimately contribute to better influenza prevention and control efforts.

Scope of the Report:

• The report analyses the Seasonal Influenza Vaccine Market by Value (USD Million).

• The report presents the analysis of Seasonal Influenza Vaccine Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

• The report analyses the Seasonal Influenza Vaccine Market by Vaccine Type (Inactivated Influenza Vaccine (IIV), Live Attenuated Influenza Vaccine (LAIV)).

• The report analyses the Seasonal Influenza Vaccine Market by Valency (Quadrivalent, Trivalent).

• The report analyses the Seasonal Influenza Vaccine Market by Age Group (Pediatrics, Adults, Elderly).

• The report analyses the Seasonal Influenza Vaccine Market by Distribution Channel (Hospitals, Pharmacies, Government Supply).

• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by services, by mode of operation & by end users.

• Also, the major opportunities, trends, drivers and challenges of the industry has been analyzed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include CSL Seqirus, GlaxoSmithKline, Sanofi, AstraZeneca, Abbott Laboratories, Viatris, Sinovac Biotech, Serum Institute of India, Daiichi Sankyo, and Dalian Aleph Biomedical.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（通信回線）の最新刊レポート

Azoth Analytics 社の最新刊レポート

本レポートと同じKEY WORD（vaccine）の最新刊レポート

よくあるご質問

Azoth Analytics社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

季節性インフルエンザワクチンの世界市場（2023年版）：ワクチンタイプ別（不活化、弱毒化）、価数別（4価、3価）、年齢層別、流通チャネル別、地域別、国別の分析：市場インサイトと予測（2019-2029年）

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（通信回線）の最新刊レポート

Azoth Analytics 社の最新刊レポート

本レポートと同じKEY WORD（vaccine）の最新刊レポート

よくあるご質問

Azoth Analytics社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?